NJ Overrides Washington to Expand & Protect COVID-19 Vaccine Access

TRENTON, N.J. — The New Jersey Department of Health (NJDOH) has issued Executive Directive No. 25-003 and an accompanying Standing Order to ensure statewide access to COVID-19 vaccines during the 2025–2026 respiratory virus season. The directive allows anyone aged six months or older to receive the vaccine, while the standing order enables pharmacists to administer vaccinations without requiring individual prescriptions.

The policy shift, announced on September 9, 2025, comes in response to recent federal changes that narrowed COVID-19 vaccine eligibility. The U.S. Food and Drug Administration (FDA) recently rescinded its Emergency Use Authorizations for COVID-19 vaccines and limited access to individuals 65 and older or those with unspecified high-risk conditions. The action was announced by U.S. Health and Human Services Secretary Robert F. Kennedy, Jr., but bypassed the typical federal scientific review process, prompting confusion among public health officials.

“At a time when COVID-19 cases are increasing across the country and as part of my Administration’s dedication to evidence-based public health action, I am committed to ensuring everyone in New Jersey who wants to receive a COVID-19 vaccination can receive a dose this fall from trusted health professionals,” said Governor Phil Murphy.

“New Jersey is committed to defending the principles that safeguard our families and protect the health of our communities. This is about equitable access to the COVID-19 vaccine, which has been proven to prevent serious illness and hospitalization,” said Acting Health Commissioner Jeff Brown. “Especially as we enter cold and flu season and as students head back-to-school, New Jerseyans are reminded to stay up to date on all recommended vaccinations.”

New Jersey Maintains Broader Vaccine Access

Signed by Acting Health Commissioner Brown, the executive directive reaffirms New Jersey’s commitment to broader vaccine access. The Standing Order, authorized by Deputy Commissioner Novneet Sahu, MD, MPA, functions as a universal prescription, allowing any person aged three and older to receive an FDA-approved COVID-19 vaccine at a pharmacy. Children under the age of three can continue to receive vaccines through their healthcare providers.

The directive is grounded in recommendations from major medical organizations, including the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, 

the American Academy of Family Physicians, and the Vaccine Integrity Project at the University of Minnesota.

The NJDOH continues to recommend consultation with healthcare providers regarding personal risk factors and vaccination benefits, particularly for individuals with underlying medical conditions. Previously identified high-risk groups by the Centers for Disease Control and Prevention (CDC) include individuals who are pregnant, have asthma or diabetes, or are physically inactive, among others.

“While COVID-19 has become part of our lives, we still have effective tools to minimize outbreaks and reduce the risk of serious complications,” said Deputy Commissioner Dr. Sahu. “Vaccines remain our strongest defense, helping to limit the spread of the virus, protecting individuals and communities, and reducing broader social impacts such as missed school and work, and reducing pressure on our health care systems."

Access and Insurance Coverage

The Murphy Administration has urged health insurance carriers to continue covering the cost of COVID-19 vaccines without cost-sharing for all individuals aged six months and older. However, coverage is not guaranteed across all plans. The Department of Health has convened an Interagency Vaccine Workgroup to address potential disruptions in vaccine access and coverage, including representatives from the Department of Human Services, the Department of Education, the Department of Banking and Insurance, the Division of Consumer Affairs, and the Department of the Treasury.

“This is about empowering residents to make decisions about their own health,” added Acting Commissioner Brown. “It’s also part of a statewide effort that includes coordinating with our sister agencies to protect access to vaccines for anyone who chooses to get one."

Vaccine Availability

COVID-19 vaccines for the 2025–2026 season are currently available at some locations in New Jersey, with broader statewide availability expected in the coming weeks. Vaccines will be distributed through Primary care providers, Chain pharmacies, Federally Qualified Health Centers, and Other participating health institutions.

Residents can locate nearby vaccine providers by visiting Vaccines.gov. Additional information about COVID-19 and other vaccine access in New Jersey can be found at nj.gov/health/vaccines.

These steps are part of New Jersey’s ongoing efforts to maintain public health preparedness and ensure affordable, equitable access to preventive care throughout the state.

For updates, subscribe to our free newsletter!

Support your local news!